GPT and metabolic dysfunction-associated steatotic liver disease: Surrogate biochemical indexes like aminotransferases, in particular alanine aminotransferase (ALT), are more frequently used standard to determine the start of treatment, as they were associated with NASH and advanced fibrosis and easy to obtain.[5] Hence, patients with NAFLD with abnormal transaminase were main targeted population in clinical intervention.